• Roxana Daneshjou, Rachel Huddart, Teri E Klein, and Russ B Altman.
• Department of Dermatology, Stanford School of Medicine, Redwood City, California. roxanad@stanford.edu.
• Semin Cutan Med Surg. 2019 Mar 1; 38 (1): E19-E24.

AbstractPharmacogenomics aims to associate human genetic variability with differences in drug phenotypes in order to tailor drug treatment to individual patients. The massive amount of genetic data generated from large cohorts of patients with variable drug phenotypes have led to advances in this field. Understanding the application of pharmacogenomics in dermatology could inform clinical practice and provide insight for future research. The Pharmacogenomics Knowledge Base and the Clinical Pharmacogenetics Implementation Consortium are among the resources to help clinicians and researchers navigate the many gene-drug associations that have already been discovered. The implementation of clinical pharmacogenomics within health care systems remains an area of ongoing development. This review provides an introduction to the field of pharmacogenomics and to current pharmacogenomics resources using examples of gene-drug associations relevant to the field of dermatology.©2019 Frontline Medical Communications.

11 keywords...

hide…